We are live on ! Find out more

577 hedge funds and large institutions have $3.17B invested in Haleon in 2023 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 163 increasing their positions, 195 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more call options, than puts

Call options by funds: $3.74M | Put options by funds: $2.69M

11% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 64

5% more capital invested

Capital invested by funds: $3.02B → $3.17B (+$158M)

0% more funds holding

Funds holding: 576577 (+1)

0.09% more ownership

Funds ownership: 4.01%4.1% (+0.09%)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

16% less repeat investments, than reductions

Existing positions increased: 163 | Existing positions reduced: 195

Holders
577
Holders Change
+1
Holders Change %
+0.17%
% of All Funds
9.06%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.09%
New
71
Increased
163
Reduced
195
Closed
64
Calls
$3.74M
Puts
$2.69M
Net Calls
+$1.05M
Net Calls Change
+$319K
Name Holding Trade Value Shares
Change
Change in
Stake
VanEck Associates
26
VanEck Associates
New York
$17.4M +$282K +33,032 +2%
RJA
27
Raymond James & Associates
Florida
$17.3M -$579K -67,813 -3%
Wells Fargo
28
Wells Fargo
California
$17.3M -$2.86M -335,630 -14%
MGCM
29
Mane Global Capital Management
New York
$14.3M +$975K +114,276 +7%
UBS Group
30
UBS Group
Switzerland
$13.7M -$1.23M -144,407 -8%
LPL Financial
31
LPL Financial
California
$12.8M +$261K +30,633 +2%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$11.2M +$1.96M +229,850 +21%
HCM
33
Heathbridge Capital Management
Ontario, Canada
$10.7M +$10.9M +1,281,000 New
KBG
34
Kahn Brothers Group
New York
$10.6M -$946K -110,834 -8%
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
$9.88M -$797K -93,363 -7%
Stifel Financial
36
Stifel Financial
Missouri
$9.42M +$1.73M +202,158 +22%
EWA
37
Exencial Wealth Advisors
Oklahoma
$8.73M +$8.52M +998,812 +2,326%
CCP
38
Clifford Capital Partners
Utah
$8.73M -$15.9K -1,863 -0.2%
Russell Investments Group
39
Russell Investments Group
United Kingdom
$8.06M -$7.99M -935,745 -49%
Citigroup
40
Citigroup
New York
$7.54M +$1.1M +128,362 +17%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$7.32M -$267K -31,276 -3%
First Eagle Investment Management
42
First Eagle Investment Management
New York
$7.3M -$354K -41,518 -5%
GH
43
GAM Holding
Switzerland
$6.7M -$11.4K -1,331 -0.2%
BCPE
44
Bain Capital Public Equity
Massachusetts
$5.77M -$610K -71,453 -9%
WF
45
Welch & Forbes
Massachusetts
$5.44M -$34 -4 -0%
Truist Financial
46
Truist Financial
North Carolina
$5.42M +$3.18M +372,139 +135%
PI
47
PFS Investments
Georgia
$4.99M +$1.17M +137,467 +30%
MPEM
48
Marathon Partners Equity Management
New York
$4.86M +$1.26M +147,500 +34%
BCI
49
Brinker Capital Investments
Pennsylvania
$4.65M +$261K +30,565 +6%
OPS
50
Orion Portfolio Solutions
Nebraska
$4.65M +$261K +30,565 +6%

HLN Hedge Fund Activity: Q2 2023 in Review

577 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Haleon (HLN) for Q2 2023, worth a combined $3.17B — up 5.2% from $3.02B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new HLN positions and 64 closed out — a net gain of 7 holders — while 163 added to existing stakes and 195 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $118M. The largest seller was Bain Capital Public Equity Management II, cutting an estimated $17M.

  • 577 institutional investors held Haleon (HLN) as of Q2 2023, up from 576 in Q1 2023.
  • Funds reported $3.17B of Haleon stock for Q2 2023, up 5.2% quarter-over-quarter.
  • 71 funds opened new Haleon positions in Q2 2023 and 64 closed out, a net change of +7 holders.
  • The largest Haleon buyer in Q2 2023 was Fidelity Investments, an estimated $118M added.
  • The largest Haleon seller in Q2 2023 was Bain Capital Public Equity Management II, an estimated $17M sold.

Based on aggregated 13F filings for Q2 2023.